echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > Medical News > Medical World News > Pharmaceutical companies have added code to innovate drugs, drug machine enterprises can take this opportunity.

    Pharmaceutical companies have added code to innovate drugs, drug machine enterprises can take this opportunity.

    • Last Update: 2020-08-04
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com

    Pharmaceutical Network Market Analysis, data show that as of July 28 this year, a total of 160 companies landed in A-shares, including 21 pharmaceutical and biological companies.
    and since the opening of the board, has also accumulated 29 pharmaceutical and biological companies to achieve the listing.
    it is worth noting that, in general, pharmaceutical and biological listed companies, especially those with innovative attributes, are becoming more and more the eyes of the capital market.
    its general listing, the share price will continue to rise, the market value increased.
    the wave of innovation, domestic pharmaceutical companies have added code of innovative drugs in fact, because of the efficacy of innovative drugs, safety and other aspects of significant advantages, coupled with China's pharmaceutical industry is currently showing a lack of innovation ability, innovative drugs serious lack of the situation, innovative drug research and development has become one of the key development direction of China's pharmaceutical manufacturing industry.
    in recent years, the policy has given a series of favorable support to the innovative pharmaceutical industry, such as accelerating the new drug approval and review system, the development of favorable innovative drugs such as volume procurement, as well as the Hong Kong Stock Exchange to allow unprofitable biotechnology companies to list, the opening of the board, which makes the pharmaceutical industry innovation wave more surge, domestic pharmaceutical companies have also accelerated the transformation, vigorously research and development of innovative drugs.
    it is understood that since 2016, the number of clinical applications for innovative drugs in China has started to increase significantly. According to the
    public information, the annual number of clinical applications for class 1 chemical drugs in China in 2016 was 220, increasing to 381 in 2019, of which 44.3% were anti-tumor drugs, and many varieties were in the late clinical stage.
    in addition, as of April 30, A-shares and Hong Kong stocks listed pharmaceutical companies, research and development investment exceeded 100 million yuan of 130, of which more than 1 billion yuan of 14;
    it is clear from the above that pharmaceutical companies do attach great importance to innovation.
    therefore, industry experts predict that with the refinement of the provisions of the priority review of innovative drugs and breakthrough drugs, the drug review time will be further shortened, the next three years or will be the outbreak period of China's innovative drugs market.
    pharmaceutical equipment is very important to the innovation and development of pharmaceutical companies In the pharmaceutical industry transformation is becoming more and more serious, the industry believes that pharmaceutical equipment as a pharmaceutical enterprise sedative development, production of technology and equipment support, will also face huge opportunities.
    first, the need for equipment will certainly change as pharmaceutical companies transition to biopharmaceuticals or other innovative drugs, especially as requirements for sterile equipment and microbial testing equipment are further enhanced.
    it is understood that in order to better provide protection for drug safety, drug in research and development and production of drug impurity analysis and control of the drug impurity content is very important.
    therefore, there are enterprises on the purpose of research and development to produce a UV analysis tester ZW-3, which in drug production and research, can be used to check the hormone alkaloids, vitamins and other drugs can produce fluorescent drugs quality, especially suitable for thin layer analysis, paper analysis spots and detection.
    in addition, the current pharmaceutical machine enterprises are also actively in accordance with the new demand of pharmaceutical companies, new requirements, improve the upgrading of equipment.
    for example, in terms of production capacity, improve the automation of equipment, intelligent level, to ensure production capacity, to meet the needs of enterprises high efficiency production, low-cost;
    , for pharmaceutical equipment manufacturers, the overall solution options that can support the commercialization of pharmaceutical production remain very limited.
    in order to solve this problem, many pharmaceutical machine companies are also from a single equipment supplier to the solution provider transformation and upgrading.
    concluding generally, in the context of the rapid development of innovative drugs, China's pharmaceutical equipment industry will also face certain opportunities and challenges.
    in one of the backgrounds, domestic pharmaceutical machine enterprises need to continuously increase investment in research and development innovation, strengthen the construction of talent team, and constantly enter the middle and high-end market, in order to better meet the pharmaceutical market demand, as well as pharmaceutical process production of new requirements.
    .
    This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.